✦ LIBER ✦

Differential activation of human and guinea pig complement by pentameric and hexameric IgM

✍ Scribed by Cathy Collins; Florence W. L. Tsui; Marc J. Shulman

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 272 KB
Volume: 32
Category: Article
ISSN: 0014-2980
DOI: 10.1002/1521-4141(200206)32:6<1802::aid-immu1802>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dual inhibition of human factor B activi

Dual inhibition of human factor B activity of the complement alternative pathway by guinea pig and human sera: Effect of heating and of complement activation

✍ Claude Lambré 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 373 KB

The relationship between the bactericida

The relationship between the bactericidal power of normal guinea-pig serum and complement activity

✍ Gordon, John ;Wormall, Arthur 📂 Article 📅 1928 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 940 KB

Species specificity of guinea pig and hu

Species specificity of guinea pig and human lymphotoxin colony inhibitory activity

✍ John O. Rundell; Charles H. Evans 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 542 KB

Formation and function of a complement-a

Formation and function of a complement-activating enzyme generated from factors of guinea pig serum and cobra venom

✍ M. P. Dierich; D. Bitter-Suermann; W. König; U. Hadding 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Inhibition of human and guinea pig compl

Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weight

✍ Hans-Peter T. Erke 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 711 KB

Effect of cyclopiazonic acid on delayed

Effect of cyclopiazonic acid on delayed hypersensitivity toMycobacterium tuberculosis, complement activity, serum enzymes, and bilirubin in guinea pigs

✍ John L. Richard; W. Michael Peden; Rod E. Fichtner; Richard J. Cole 📂 Article 📅 1986 🏛 Springer Netherlands 🌐 English ⚖ 369 KB

Cyclopiazonic acid (CPA) was given daily to groups of guinea pigs at doses of 0.00625, 0.0125, 0.025, 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, and 1.95 mg/day for 30 days. All guinea pigs were sensitized and survivors were skin tested twenty-five days later with Mycobacterium tuberculosis. Mortalities occurre